KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in id-KLH (26)

Friday
Jan212000

NCT00004197

Friday
Jan212000

NCT00004198

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

Conditions: Non-Hodgkin's Lymphoma
Sponsors: University of Nebraska, National Cancer Institute (NCI), Genitope Corporation
Phase II

Wednesday
Nov031999

NCT00001572

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

Conditions: B Cell Lymphoma, Follicular Lymphoma, Neoplasm
Sponsors: National Cancer Institute (NCI)
Phase I

Wednesday
Nov031999

NCT00001512

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Conditions: B Cell Lymphoma, Follicular Lymphoma, Lymphoma
Sponsors: National Cancer Institute (NCI)
Phase I

Wednesday
Nov031999

NCT00001561

Monday
Nov011999

NCT00002787

Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Conditions: Multiple Myeloma, Plasma Cell Neoplasm
Sponsors: Fred Hutchinson Cancer Research Center, National Cancer institute (NCI)
Phase I

Page 1 2 3